174 results
Page 4 of 9
8-K
EX-10.1
gqi tqmzseg4ub
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.5
pv3k 4n5uws5qhx
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.4
hf3vi
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.1
ifyuq5z71zre
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K/A
EX-10.3
x8i7k ifs
6 Mar 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
fbk7vgpaw hw44
10 Sep 13
Other Events
12:00am
8-K
EX-4.4
hr2gh257
25 Jan 13
Theravance Announces Closing of Public Offering of $287.5 Million of Convertible Subordinated Notes
12:00am
424B5
zgizrp6d63qgmmx ses
18 Jan 13
Prospectus supplement for primary offering
12:00am
S-3ASR
zoorhqfn
16 Jan 13
Automatic shelf registration
12:00am
S-3ASR
EX-4.4
idlwkhdznfodo
16 Jan 13
Automatic shelf registration
12:00am